What scientists think about Parkinson's research

A good followup question needed for stroke scientists. My comment would be that stroke research is too scattershot. No one seems to be following any plan or strategy. And then there are the ones trying for the moon shot and bypassing all the intermediate steps in between. That would be the stem cell researchers.
http://view.michaeljfox-email.org/?j=fed210707660047f&m=fe9612727165037d70&ls=fe2e15707c62067e721574&l=ff6416717d&s=fe6212717360077a7516&jb=ff6116747d&ju=fe5a157577670d7c7d1c&et_cid=403402&et_rid=61643702&et_lid=View+email+as+webpage
Dear ,
What do scientists think about the future of Parkinson's research? 
On November 3, The Michael J. Fox Foundation convened its ninth annual Parkinson's Disease Therapeutics Conference to explore that question. As we work to further these innovations and foster collaboration to speed progress, your support is critical. 
Nearly 300 researchers and business professionals came together to share the latest in Parkinson's disease (PD) research advances. These include progress toward our ultimate goal -- a treatment to slow or slow disease progression -- and technology-enabled solutions to help people living with PD today. They include:

• Use of light to turn cells "on and off" in the brain to address motor symptoms  
• Indicators for PD-related memory and thinking problems via MRI
• A promising genetic target for the development of a disease-modifying treatment 

I invite you to read more about this invigorating conference and to donate today to help MJFF push forward these advances and others at the forefront of science and technology. 
Our work is not completed until we've found a cure, and every dollar you give brings us closer.
Thank you,
Todd Sherer, PhDCEO